Library / regulatory-reference
Oman: Ministry of Health (Directorate General of Pharmaceutical Affairs and Drug Control)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Ministry of Health is Oman's national regulatory authority for medicines, acting through its pharmaceutical affairs and drug control directorate.
Oman imports most of its medicines, and the ministry's registration, import licensing and inspection decisions govern the market, which serves both a public health system and a growing private sector.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy documentation, and establishments across the supply chain are licensed and inspected.
Post-market work includes safety monitoring, quality testing and recalls, with the ministry operating drug quality-control laboratories.
Regional and international role
Oman participates in Gulf regulatory cooperation, where member states align requirements and share a joint purchasing program that influences registration planning.
Its quality-control laboratory capability gives it an analytical role beyond its market size.
Using this profile
The ministry publishes regulations and announcements in Arabic and English through its official health portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Oman illustrates the Gulf ministry regulator: import registration backed by in-country laboratory testing and joint Gulf purchasing.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.